31P NMR spectroscopy of blood plasma: Determination and quantification of phospholipid classes in patients with renal cell carcinoma

NMR in Biomedicine

Volumn 15, Issue 1, 2002, Pages 60-68

  Sullentrop F ^a   Moka, D ^a   Neubauer, S ^a   Haupt, G ^a   Engelmann, U ^a   Hahn, J ^a   Schicha, H ^a  

^a UNIVERSITY OF COLOGNE   (Germany)

Author keywords

31P NMR spectroscopy; Phospholipid metabolism; Renal cell carcinoma

Indexed keywords

BIOLOGICAL ORGANS; CELLS; ENZYME KINETICS; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PATIENT TREATMENT; PHOSPHOLIPIDS; TUMORS;

NEPHRECTOMY;

BLOOD;

LYSOPHOSPHATIDYLCHOLINE; PHOSPHATIDYLCHOLINE; PHOSPHOLIPID; PHOSPHORUS 31; PHOSPHATIDYLETHANOLAMINE; PHOSPHATIDYLINOSITOL; SPHINGOMYELIN;

ADULT; ADVANCED CANCER; AGED; ARTICLE; BENIGN TUMOR; CANCER REGRESSION; CANCER STAGING; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE MARKER; ENZYME ACTIVITY; FEMALE; GENDER; HUMAN; KIDNEY CARCINOMA; KIDNEY METASTASIS; KIDNEY PELVIS CARCINOMA; KIDNEY TUMOR; LUNG CARCINOMA; MALE; NEPHRECTOMY; PHOSPHOLIPID BLOOD LEVEL; PHOSPHORUS NUCLEAR MAGNETIC RESONANCE; PRIORITY JOURNAL; PROGNOSIS; QUANTITATIVE ANALYSIS; BLOOD; MIDDLE AGED; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; REMISSION; SEXUAL DEVELOPMENT;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, RENAL CELL; FEMALE; HUMANS; KIDNEY NEOPLASMS; LYSOPHOSPHATIDYLCHOLINES; MAGNETIC RESONANCE SPECTROSCOPY; MALE; MIDDLE AGED; PHOSPHATIDYLCHOLINES; PHOSPHATIDYLETHANOLAMINES; PHOSPHATIDYLINOSITOLS; PHOSPHOLIPIDS; REMISSION INDUCTION; SEX CHARACTERISTICS; SPHINGOMYELINS;

EID: 0036008515     PISSN: 09523480     EISSN: None     Source Type: Journal    
DOI: 10.1002/nbm.758     Document Type: Article

References (45)

1. Magnetic resonance spectroscopy in cancer: Phospholipid, neutral lipid and lipoprotein metabolism and function
2. Serum lipoprotein levels in patients with cancer
3. Phospholipid metabolites as indicators of cancer cell function
4. Magnetic resonance spectroscopy of blood plasma lipoproteins in malignant disease: Methological aspects and clinical relevance
5. Application of in vivo NMR spectroscopy to cancer
6. High resolution 31P nuclear magnetic resonance studies of intact yeast cells
7. Nuclear magnetic resonance techniques in medicine
8. Applications of 31P NMR to clinical biochemistry
9. Altered energy metabolism after myocardial infarction assessed by 31P-MR-spectroscopy in humans
10. Force output and energy metabolism during neuromuscular electrical stimulation: A 31P-NMR study
11. Magnetic resonance spectroscopy for the determination or renal metabolic rate in vivo
12. The spingolipid composition of human renal carcinoma
13. Abnormal cholesterol metabolism in renal clear cell carcinoma
14. Low density lipoprotein-receptor activity is lost in vivo in malignantly transformed renal tissue
15. Low density lipoprotein receptor and 3-hydroxy-3-methylglutaryl coenzyme A reductase mRNA levels are coordinately reduced in human renal cell carcinoma
16. Association of elevated sulfatides and sulfotransferase activities with human renal cell carcinoma
17. Sulfolipids and glycolipid sulfotransferase activities in human renal cell carcinoma cells
18. Presence and characterization of glycolipid sulfotransferase in human cancer serum
19. Changes in lipid profiles of estrogen-induced and transplanted renal carcinomas in syrian hamsters
20. Magic angle spinning proton nuclear magnetic resonance spectroscopic analysis of intact kidney tissue samples
21. 1H nuclear magnetic resonance spectroscopy
22. 31P high-resolution NMR study
23. 31P NMR spectroscopy to monitor chemotherapy-associated changes of serum phospholipids in patients with malignant lymphomas
24. 31P MRS spectra of sera from patients with multiple myeloma
25. 31P-MRS (magnetic resonance spectroscopy) spectra of sera from patients with acute leukemia
26. 31P NMR spectroscopy in clinical analysis of changes of serum phospholipids in leukemia, lymphoma and some other non-haematological cancers
27. 31P NMR spectroscopy
28. 13C enriched metabolites from cell suspensions incubated in deuterated media
29. Serum total phospholipids, lecithin and lysolecithin-normal values in various age groups
30. The natural history of renal cell carcinoma
31. Paraneoplastic manifestations of renal cell carcinoma
32. 31P nuclear magnetic resonance, phospholipid and phosphatic metabolite profiles
33. Plasma and red blood cell phospholipids in chronic liver diseases
34. Serum phospholipids in bilharzial hepatic fibrosis and chronic active hepatitis
35. 31P MRS studies on experimental tumors treated with tumor necrosis factor
36. Effects of cancer upon high-density and other lipoproteins
37. Analysis of plasma lipids by NMR spectroscopy: Application to modifications induced by malignant tumors
38. Decreased plasma lecithin:cholesterol acyltransfer and associated changes in plasma and red cell lipids in uraemia
39. Plasma phospholipids and platelet function in uremic patients
40. Erythrocyte and plasma lipids in terminal renal insufficiency
41. Alterations in proportions of serum phospholipids in chronic renal failure
42. Abnormal acyltransferase activities and accelerated cholesteryl ester transfer in patients with nephrotic syndrome
43. Lipoproteins, apolipoproteins, lipoprotein lipase, hepatic triglyceride lipase and lecithin cholesterol acyltransferase in patients with nephrotic syndrome